Medibank Private Ltd (MPL)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 4.990 |
|---|---|
| 52-week range | 4.060 – 5.310 |
| Return, 1 month / 3 months | +9.4% / −0.1% |
| Return, 1 year / 3 years | +9.1% / +61.0% |
| Trend | Uptrend |
| RSI (14) | 74 |
| Volatility (1 year) | 21.2% |
| Worst drawdown (1 year) | -16.8% |
| Average daily value traded | 33.18M AUD |
| Dividend yield | 3.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Medibank Private is an Australian health insurer based in Melbourne. It provides private health insurance to individuals and families, covering hospital treatment and extras such as dental, optical and physiotherapy services. The company also offers related insurance products, including travel and pet cover, and serves customers across Australia through its own brand and its subsidiary brands. Its customers are mainly people seeking private cover for themselves and their families.
The shares are listed on the Australian Securities Exchange in Australia under the code MPL, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Medibank Private Ltd (MPL) trades on the Australian Securities Exchange in Australia. It last closed at AUD 4.990 on 23 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 85 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.1% and over the last three months it fell 0.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.3% | ||
| From 52-week high | -5.5% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -0.1% | ||
| 6-month return | 11.7% | ||
| 12-month return, skipping the last month | -0.3% | ||
| Stability (higher is calmer) | 94 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.8% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 33.18M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.3% |
|---|---|
| 1 month | +9.4% |
| 3 months | −0.1% |
| 6 months | +11.7% |
| 1 year | +9.1% |
| 3 years | +61.0% |
| 5 years | +76.3% |
Signals
| 50-day / 200-day average | 4.666 / 4.608 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.086 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Sep 2026 | AUD 0.1090 |
| 26 Feb 2026 | AUD 0.0830 |
| 10 Sep 2025 | AUD 0.1020 |
| 6 Mar 2025 | AUD 0.0780 |
| 4 Sep 2024 | AUD 0.0940 |
| 29 Feb 2024 | AUD 0.0720 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.